This study employed phosphoproteomic analysis to investigate ARID1A phosphorylation in breast cancer, identifying predominant phosphosites-S363, S1184, and S696-regulated by kinases such as MAPK14, CDK16, and MAPK9. Here, CDK16 is linked to breast carcinoma.